关于 Ticagrelor
- 原研厂家
- AstraZeneca
- 适应症
- Stroke; Acute Coronary Syndrome ; Myocardial Infarction; Peripheral Vascular Disease
- 获批日期
- 09/03/2015
- DS/DP
- 04/30/2025
可供应中间体
当前列出 Ticagrelor 的 7 个中间体。可就下方任一产品索取规格、文件或报价。
| 产品名称 | CAS 号 | 分子式 | 物理性质 |
|---|---|---|---|
| 4,6-Dichloro-2-(propylthio)pyrimidin -5-amine | 145783-15-9 | / | / |
| 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro -3aH-cyclopenta[d][1,3]dioxol -4-yloxy)ethanol L-tataric acid | 376608-65-0 | / | / |
| (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium(2R)hydroxy(phenyl)ethanoate | 376608-71-8 | / | / |
| Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- | 376608-74-1 | / | / |
| (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 | / | / |
| Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S) -(2R,3R)-2,3-dihydroxybutanedioate (1:1) | 220352-39-6 | / | / |
| 2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol | 274693-26-4 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →